Gastro-oesophageal reflux: An overview of the pharmacotherapeutic treatment options

L. Malan; Q. Labuschagne; N. Schellack; G. Schellack; J. C. Meyer

Gastro-oesophageal reflux: An overview of the pharmacotherapeutic treatment options

L. Malan, Q. Labuschagne, N. Schellack^*, G. Schellack, J. C. Meyer

^*Corresponding author for this work

Research output: Contribution to journal › Review article › peer-review

Abstract

Gastro-oesophageal reflux disease (GORD) produces symptoms that cause great irritation to the patient. Pharmacotherapeutic management is directed at minimising these symptoms and reducing the causative factors, e.g. acid production, thereby providing relief. Currently available agents include simple antacids and acid suppression therapy, including histamine 2-receptor antagonists, proton pump inhibitors, mucosal or cytoprotective agents and pro-motility agents.

Original language	English
Pages (from-to)	31-36
Number of pages	6
Journal	SA Pharmaceutical Journal
Volume	84
Issue number	1
Publication status	Published - 2017

Keywords

GORD
Gastro-oesophageal reflux
PPIs
Proton-pump inhibitors

Cite this

@article{11b9d54d98e2428189854c4e845c17ed,

title = "Gastro-oesophageal reflux: An overview of the pharmacotherapeutic treatment options",

abstract = "Gastro-oesophageal reflux disease (GORD) produces symptoms that cause great irritation to the patient. Pharmacotherapeutic management is directed at minimising these symptoms and reducing the causative factors, e.g. acid production, thereby providing relief. Currently available agents include simple antacids and acid suppression therapy, including histamine 2-receptor antagonists, proton pump inhibitors, mucosal or cytoprotective agents and pro-motility agents.",

keywords = "GORD, Gastro-oesophageal reflux, PPIs, Proton-pump inhibitors",

author = "L. Malan and Q. Labuschagne and N. Schellack and G. Schellack and Meyer, {J. C.}",

note = "Publisher Copyright: {\textcopyright} Medpharm.",

year = "2017",

language = "English",

volume = "84",

pages = "31--36",

journal = "SA Pharmaceutical Journal",

issn = "1015-1362",

publisher = "Medpharm Publications",

number = "1",

}

TY - JOUR

T1 - Gastro-oesophageal reflux

T2 - An overview of the pharmacotherapeutic treatment options

AU - Malan, L.

AU - Labuschagne, Q.

AU - Schellack, N.

AU - Schellack, G.

AU - Meyer, J. C.

N1 - Publisher Copyright: © Medpharm.

PY - 2017

Y1 - 2017

N2 - Gastro-oesophageal reflux disease (GORD) produces symptoms that cause great irritation to the patient. Pharmacotherapeutic management is directed at minimising these symptoms and reducing the causative factors, e.g. acid production, thereby providing relief. Currently available agents include simple antacids and acid suppression therapy, including histamine 2-receptor antagonists, proton pump inhibitors, mucosal or cytoprotective agents and pro-motility agents.

AB - Gastro-oesophageal reflux disease (GORD) produces symptoms that cause great irritation to the patient. Pharmacotherapeutic management is directed at minimising these symptoms and reducing the causative factors, e.g. acid production, thereby providing relief. Currently available agents include simple antacids and acid suppression therapy, including histamine 2-receptor antagonists, proton pump inhibitors, mucosal or cytoprotective agents and pro-motility agents.

KW - GORD

KW - Gastro-oesophageal reflux

KW - PPIs

KW - Proton-pump inhibitors

UR - http://www.scopus.com/inward/record.url?scp=85016983794&partnerID=8YFLogxK

M3 - Review article

AN - SCOPUS:85016983794

SN - 1015-1362

VL - 84

SP - 31

EP - 36

JO - SA Pharmaceutical Journal

JF - SA Pharmaceutical Journal

IS - 1

ER -

Gastro-oesophageal reflux: An overview of the pharmacotherapeutic treatment options

Abstract

Keywords

Other files and links

Fingerprint

Cite this